ADCT
ADC Therapeutics S.A. (ADCT)
NYSE · Healthcare
ADC Therapeutics S.A. annual/quarterly cash on hand history from 2022 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- ADC Therapeutics S.A. cash on hand for the quarter ending December 31, 2025 were 261.3M, a 4.17% increase year-over-year.
- ADC Therapeutics S.A. cash on hand for 2025 were 261.3M, a 4.17% increase from 2024.
- ADC Therapeutics S.A. cash on hand for 2024 were 250.9M, a 9.95% decrease from 2023.
- ADC Therapeutics S.A. cash on hand for 2023 were 278.6M, a 14.66% decrease from 2022.
- ADC Therapeutics S.A. cash on hand for 2022 were 326.4M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| ADC Therapeutics S.A. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $261 |
| 2024 | $251 |
| 2023 | $279 |
| 2022 | $326 |
| ADC Therapeutics S.A. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $261 |
| 2024-12-31 | $251 |
| 2023-12-31 | $279 |
| 2022-12-31 | $326 |
ADC Therapeutics S.A. Cash on Hand — FAQ
ADC Therapeutics S.A. (ADCT) cash on hand over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ADCT's cash on hand history?
The chart and table above show ADC Therapeutics S.A.'s cash on hand by year and by quarter, including the growth rate.